Editorial: Cell cycle control as a new therapeutic approach for SARS-CoV-2 infection
Front Pharmacol
.
2023 Feb 1:14:1136277.
doi: 10.3389/fphar.2023.1136277.
eCollection 2023.
Authors
Roberta Rizzo
1
,
Francesca Caccuri
2
,
Giuseppe Valacchi
3
,
Giorgio Zauli
4
Affiliations
1
Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy.
2
Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
3
Plants for Human Health Institute, North Carolina State University, Kannapolis, NC, United States.
4
Research Department, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
PMID:
36817134
PMCID:
PMC9929526
DOI:
10.3389/fphar.2023.1136277
No abstract available
Keywords:
SARS-CoV-2; cell cycle; cytokine storm; idasanutlin; p53.
Publication types
Editorial